Your browser doesn't support javascript.
loading
Refining nosology by modelling variation among facial phenotypes: the RASopathies.
Matthews, Harold; Vanneste, Michiel; Katsura, Kaitlin; Aponte, David; Patton, Michael; Hammond, Peter; Baynam, Gareth; Spritz, Richard; Klein, Ophir D; Hallgrimsson, Benedikt; Peeters, Hilde; Claes, Peter.
Afiliação
  • Matthews H; Department of Human Genetics, KU Leuven, Leuven, Flemish Brabant, Belgium.
  • Vanneste M; Medical Imaging Research Center, UZ Leuven, Leuven, Flemish Brabant, Belgium.
  • Katsura K; Facial Sciences Research Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Aponte D; Department of Human Genetics, KU Leuven, Leuven, Flemish Brabant, Belgium.
  • Patton M; Medical Imaging Research Center, UZ Leuven, Leuven, Flemish Brabant, Belgium.
  • Hammond P; Program in Craniofacial Biology, Departments of Orofacial Sciences and Pediatrics, and Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA.
  • Baynam G; Department of Cell Biology and Anatomy, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
  • Spritz R; Medical Genetics Unit, St George's University of London, London, UK.
  • Klein OD; Department of Human Genetics, KU Leuven, Leuven, Flemish Brabant, Belgium.
  • Hallgrimsson B; Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital, Perth, Western Australia, Australia.
  • Peeters H; Telethon Kids Institute and Division of Paediatrics, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia.
  • Claes P; School of Earth and Planetary Sciences, Faculty of Science and Engineering, Curtin University, Perth, Western Australia, Australia.
J Med Genet ; 2022 Jul 20.
Article em En | MEDLINE | ID: mdl-35858754
ABSTRACT

BACKGROUND:

In clinical genetics, establishing an accurate nosology requires analysis of variations in both aetiology and the resulting phenotypes. At the phenotypic level, recognising typical facial gestalts has long supported clinical and molecular diagnosis; however, the objective analysis of facial phenotypic variation remains underdeveloped. In this work, we propose exploratory strategies for assessing facial phenotypic variation within and among clinical and molecular disease entities and deploy these techniques on cross-sectional samples of four RASopathies Costello syndrome (CS), Noonan syndrome (NS), cardiofaciocutaneous syndrome (CFC) and neurofibromatosis type 1 (NF1).

METHODS:

From three-dimensional dense surface scans, we model the typical phenotypes of the four RASopathies as average 'facial signatures' and assess individual variation in terms of direction (what parts of the face are affected and in what ways) and severity of the facial effects. We also derive a metric of phenotypic agreement between the syndromes and a metric of differences in severity along similar phenotypes.

RESULTS:

CFC shows a relatively consistent facial phenotype in terms of both direction and severity that is similar to CS and NS, consistent with the known difficulty in discriminating CFC from NS based on the face. CS shows a consistent directional phenotype that varies in severity. Although NF1 is highly variable, on average, it shows a similar phenotype to CS.

CONCLUSIONS:

We established an approach that can be used in the future to quantify variations in facial phenotypes between and within clinical and molecular diagnoses to objectively define and support clinical nosologies.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article